Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Blood|April 24, 2019
IGF1R as druggable target mediating PI3K-δ inhibitor resistance in a murine model of chronic lymphocytic leukemiaAnnika Scheffold, Billy Michael Chelliah Jebaraj, Eugen Tausch, et al.
Science Immunology|July 30, 2017
Tumor-derived exosomes modulate PD-L1 expression in monocytesFranziska Haderk, Ralph Schulz, Murat Iskar, et al.
Blood Advances|March 2, 2021
Proteomic and bioinformatic profiling of neutrophils in CLL reveals functional defects that predispose to bacterial infectionsNirojah Subramaniam, Jenny Bottek, Stephanie Thiebes, et al.
European Journal of Immunology|March 31, 2021
Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patientsIgor Kos, Benedikt Balensiefer, Vadim Lesan, et al.
Genome Medicine|March 20, 2020
Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLLJustyna A Wierzbinska, Reka Toth, Naveed Ishaque, et al.
Cell Reports|March 16, 2026
Integrin-dependent neutrophil slowing reduces lung perfusion and supports metastasis in a model of breast cancerFrédéric Fercoq, Gemma S Cairns, Victoria L Bridgeman, et al.
Blood|January 29, 2021
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic targetEmma Kennedy, Eve Coulter, Emma Halliwell, et al.
Immunity|December 8, 2021
Interleukin-10 receptor signaling promotes the maintenance of a PD-1<sup>int</sup> TCF-1<sup>+</sup> CD8<sup>+</sup> T cell population that sustains anti-tumor immunityBola S Hanna, Laura Llaó-Cid, Murat Iskar, et al.
Nature Communications|January 25, 2025
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLLLavinia Arseni, Gianluca Sigismondo, Haniyeh Yazdanparast, et al.
Nature Cell Biology|February 21, 2024
Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entitiesTobias Roider, Marc A Baertsch, Donnacha Fitzgerald, et al.
Pageof 7